Showing 1-10 of 17 results
-
What to know about dengue fever as cases spread
New York Times, Published on 25/10/2023
» NEW YORK - Cases of dengue fever, a mosquito-borne viral illness that can be fatal, are surging around the world. The increase is occurring both in places that have long struggled with the disease and in areas where its spread was unheard-of until the last year or two, including France, Italy and Chad, in central Africa. Last week, health officials in Pasadena, California, reported a first case of locally transmitted dengue.
-
Pregnancy and Covid: What women need to know
New York Times, Published on 16/03/2023
» Pregnant women are particularly vulnerable to Covid-19, and new government data show that maternal mortality rose sharply in 2021, the second year of the pandemic. Here is what women need to know to keep themselves safe.
-
Camilla tests positive for coronavirus
New York Times, Published on 14/02/2022
» LONDON: Camilla, the wife of Prince Charles, has tested positive for the coronavirus, four days after her husband was reported to be reinfected, Clarence House, their royal household, said Monday.
-
No, athletes are not dying from Covid-19 vaccines
New York Times, Published on 29/01/2022
» The conspiracy theory that athletes are collapsing or dying after receiving a Covid-19 vaccine resurfaced this week after two prominent voices advanced the idea.
-
CDC: Covid may raise risk of diabetes in children
New York Times, Published on 08/01/2022
» Children who have recovered from Covid-19 appear to be at significantly increased risk of developing Type 1 or Type 2 diabetes, researchers at the Centers for Disease Control and Prevention reported Friday.
-
Pfizer says its booster offers strong protection against Omicron
New York Times, Published on 09/12/2021
» WASHINGTON: Pfizer and BioNTech said Wednesday that laboratory tests suggest a booster shot of their coronavirus vaccine offers significant protection against the fast-spreading omicron variant of the virus.
-
Merck will share formula for its Covid pill with poor countries
New York Times, Published on 29/10/2021
» Merck has granted a royalty-free licence for its promising COVID-19 pill to a United Nations-backed nonprofit in a deal that would allow the drug to be manufactured and sold cheaply in the poorest nations, where vaccines for the coronavirus are in devastatingly short supply.
-
Protesters are back, and angrier, as govt fumbles on Covid
New York Times, Published on 06/09/2021
» In air heavy with monsoonal pressure and discontent, the riot police in Bangkok unleashed rubber bullets and tear gas. Tanat Thanakitamnuay, the scion of a real estate family, stood on a truck, where he had been excoriating Thailand’s leaders for their bungled response to the pandemic.
-
Unmasked Songkran parties dent Phuket’s reopening hopes
New York Times, Published on 26/04/2021
» PHUKET: Around the corner from the teeth-whitening clinic and the tattoo parlour with offerings in Russian, Hebrew and Chinese, near the outdoor eatery with fried rice meant to fuel sunburned tourists or tired go-go dancers, the Hooters sign has lost its H.
-
US health officials question AstraZeneca trial results
New York Times, Published on 23/03/2021
» ์NEW YORK: US federal health officials said early Tuesday that results from a US trial of AstraZeneca’s Covid-19 vaccine may have relied on "outdated information" that "may have provided an incomplete view of the efficacy data", casting doubt on an announcement Monday that had been seen as good news for the British-Swedish company, as well as the global vaccination drive.
Your recent history
-
Recently searched
-
Recently viewed links